Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$486.62 USD

486.62
740,884

+1.86 (0.38%)

Updated Oct 2, 2024 04:00 PM ET

Pre-Market: $482.00 -4.62 (-0.95%) 9:24 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 23% (59 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Intuitive Surgical (ISRG) Reports Next Week: Wall Street Expects Earnings Growth

Intuitive Surgical (ISRG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stock Market News For Mar 18, 2019

Markets closed in the green on Friday as optimism around a U.S. - China trade deal boosted investor sentiment.

Intuitive Surgical da Vinci SP Gets FDA Nod, Prospects Bright

Intuitive Surgical (ISRG) fortifies its foothold in the global robotic-surgery market.

Intuitive Surgical (ISRG) Stock Sinks As Market Gains: What You Should Know

Intuitive Surgical (ISRG) closed at $558.29 in the latest trading session, marking a -0.08% move from the prior day.

RTI Surgical Buys Paradigm Spine, Adds Coflex to Portfolio

RTI Surgical's (RTIX) acquisition of Paradigm Spine aligns with the former's goal of expanding its spine portfolio.

Mark Vickery headshot

Top Stock Reports for Visa, Honeywell & Biogen

Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Honeywell (HON) and Biogen (BIIB).

Intuitive Surgical (ISRG) Up 2.9% Since Last Earnings Report: Can It Continue?

Intuitive Surgical (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Intuitive Surgical (ISRG) Gains As Market Dips: What You Should Know

In the latest trading session, Intuitive Surgical (ISRG) closed at $549.87, marking a +0.04% move from the previous day.

Intuitive Surgical Gets FDA Nod for Ion Endoluminal System

The regulatory go-ahead for the Ion platform is likely to provide Intuitive Surgical (ISRG) a competitive edge in the minimally-invasive-care space.

Here's Why You Should Hold Intuitive Surgical (ISRG) Stock

Intuitive Surgical's (ISRG) solid exposure to robotics & medical mechatronics is commendable. Its robot-based da Vinci Surgical System for minimally-invasive surgery is an added positive.

Mark Vickery headshot

Top Stock Reports for United Technologies, Lockheed Martin & NextEra Energy

Today's Research Daily features new research reports on 16 major stocks, including United Technologies (UTX), Lockheed Martin (LMT) and NextEra Energy (NEE).

Intuitive Surgical (ISRG) Dips More Than Broader Markets: What You Should Know

Intuitive Surgical (ISRG) closed at $494.25 in the latest trading session, marking a -0.5% move from the prior day.

Accuray & China Isotope Collaborate to Sell Radiation Devices

Management at Accuray (ARAY) sees bright prospects in China.

Has Intuitive Surgical (ISRG) Outpaced Other Medical Stocks This Year?

Is (ISRG) Outperforming Other Medical Stocks This Year?

Stock Market News for Jan 25, 2019

Wall Street ended mixed on Thursday after investors received strong earnings numbers amidst lingering concerns over trade negotiations.

Intuitive Surgical (ISRG) Earnings Miss, Revenues Beat in Q4

Solid show by flagship da Vinci system drives Intuitive Surgical's (ISRG) Q4 results.

The Zacks Analyst Blog Highlights: Intel, Starbucks, Intuitive Surgical and Western Digital

The Zacks Analyst Blog Highlights: Intel, Starbucks, Intuitive Surgical and Western Digital

Mark Vickery headshot

Post-Bell Q4 Highlights: Intel, Starbucks & More

We see a fresh new crop of Q4 earnings reports hitting the tape, with INTC and SBUX leading the way.

Will Flagship Impella Drive ABIOMED's (ABMD) Q3 Earnings?

ABIOMED (ABMD) is likely to gain from flagship Impella in third-quarter fiscal 2019; positive trends in the CHD markets buoy optimism.

Will Core Renal Care Unit Fuel Baxter's (BAX) Q4 Earnings?

Management at Baxter (BAX) expects Renal Care to see growth of 3-4% in 2018.

Can Diagnostic Revenues Fuel PerkinElmer's (PKI) Q4 Earnings?

PerkinElmer's (PKI) fourth-quarter 2018 results are likely to benefit from the Diagnostics Segment's solid performance.

Accuray's (ARAY) Q2 Loss Narrows, Radixact Demand Shoots Up

Demand for flagship Radixact & CyberKnife platforms aids Accuray's (ARAY) fiscal Q2 results.

Why Earnings Season Could Be Great for Intuitive Surgical (ISRG)

Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

CONMED (CNMD) Q4 Earnings Match Estimates, Revenues Beat

CONMED's (CNMD) Q4 results get a boost from solid segmental performances.

ISRG, RMD Earnings on Jan 24: Here Are the Key Predictions

Let's take a look at the factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical space.